These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5003141)

  • 1. [Xylitol and its possible clinical use].
    Rogala H; Sieradzki J
    Przegl Lek; 1971; 28(12):802-6. PubMed ID: 5003141
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased serum concentrations of lactic, pyruvic and uric acid and bilibubin after postoperative xylitol infusion.
    Korttila K; Mattila MA
    Acta Anaesthesiol Scand; 1979 Jun; 23(3):273-7. PubMed ID: 484184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xylitol--clinical pharmacology in normal adult volunteers.
    Dohahoe JF; Powers RJ
    J Clin Pharmacol; 1974; 14(5-6):255-60. PubMed ID: 4829518
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of xylitol in long-term parenteral nutrition in dogs.
    Meng HC; Anderson GE
    Z Ernahrungswiss Suppl; 1973; 15():54-68. PubMed ID: 4201154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Xylitol used as a glucose substitute in the disordered glucose assimilation of postaggression syndrome. Review of animal experiment and clinical studies].
    Schultis K
    Z Ernahrungswiss Suppl; 1971; 11():87-97. PubMed ID: 5003382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current status of xylitol].
    Sintesi
    Acta Diabetol Lat; 1970; 7(6):1033-62. PubMed ID: 4996430
    [No Abstract]   [Full Text] [Related]  

  • 7. A bioelectronic system for insulin release triggered by ketone body mimicking diabetic ketoacidosis in vitro.
    Gamella M; Guz N; Pingarrón JM; Aslebagh R; Darie CC; Katz E
    Chem Commun (Camb); 2015 May; 51(36):7618-21. PubMed ID: 25846235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic bases of the treatment of coma in the diabetic patient].
    Pestel M
    Presse Med (1893); 1969 Mar; 77(13):479-81. PubMed ID: 4978686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of i.v. administration of xylitol and sorbitol to diabetics].
    Dubach UC
    Int Z Vitam Ernahrungsforsch Beih; 1976; 15():81-91. PubMed ID: 1066338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravenous carbohydrates on various parameters in blood.
    Foerster H
    Z Ernahrungswiss; 1972 Sep; 11(3):227-31. PubMed ID: 4642115
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fat and uric acid metabolism during acute effect of oxylitol].
    Mertz DP; Kaiser V; Klöpfer-Zaar M; Beisbarth H
    Klin Wochenschr; 1972 Dec; 50(23):1097-106. PubMed ID: 4643488
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parenteral feeding. Biochemical and clinical findings during continuous long-term infusion of glucose, fructose, sorbitol and xylitol. 2. Clinical aspects, discussion and results].
    Förster H; Heller L; Hellmund U; Boecker S
    Fortschr Med; 1975 Sep; 93(27):1257-61. PubMed ID: 816722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Xylitol, metabolism and clinical use].
    Lang K
    Klin Wochenschr; 1971 Mar; 49(5):233-45. PubMed ID: 4994068
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of Consuming Xylitol on Gut Microbiota and Lipid Metabolism in Mice.
    Uebanso T; Kano S; Yoshimoto A; Naito C; Shimohata T; Mawatari K; Takahashi A
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28708089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of uric acid after infusion of carbohydrates].
    Berg G
    Z Ernahrungswiss; 1973 Dec; 12(4):280-1. PubMed ID: 4781868
    [No Abstract]   [Full Text] [Related]  

  • 16. [Infusion velocity and tolerance of xylitol solution].
    Igarashi T; Shoji T; Yamamoto H; Tanabe Y; Miyakawa T; Nakajima Y; Kobayashi M
    Z Ernahrungswiss Suppl; 1971; 11():20-8. PubMed ID: 5290592
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic aspects of metabolic effects of xylitol in diabetics].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Z Inn Med; 1971; 52(1):70-4. PubMed ID: 5540821
    [No Abstract]   [Full Text] [Related]  

  • 18. Human erythrocyte phosphoribosylpyrophosphate content and "generation" during a constant rate infusion of xylitol.
    Kaiser W; Stocker K; Heuckenkamp PU
    Adv Exp Med Biol; 1974; 41():479-82. PubMed ID: 4364980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Side effects of sugar substitutes].
    Förster H
    Dtsch Zahnarztl Z; 1977; 32(5 Suppl 1):S43-53. PubMed ID: 266469
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carbohydrate infusion in internal diseases. A comparative study in metabolically healthy, liver diseased and diabetic patients. VI. Infusions of a glucose/xylitol mixture (1:1 ratio) over a 48-hour period].
    Egberts EH; Rittershofer H; Müller PH; Schmülling R; Prestele H; Horbach L; Malchow H
    Infusionsther Klin Ernahr; 1982 Apr; 9(2):92-6. PubMed ID: 7044970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.